Table 1.
Overall | CMV reactivation | |||
---|---|---|---|---|
N = 71 | Yes (n = 13, 18.3%) | No (n = 58, 81.7%) | P | |
Age (yr) | 64 ± 14 | 68 ± 12 | 63 ± 14 | 0.20 |
Gender, n (%) | 0.37 | |||
Male | 58 (81.7) | 9 (69.2) | 49 (84.5) | - |
Female | 13 (18.3) | 4 (30.8) | 9 (15.5) | - |
Height (cm) | 168 (160–171) | 160 (160–167) | 168 (160–172) | 0.10 |
Weight (kg)a | 58.5 ± 11.8 | 51.1 ± 10.6 | 61.6 ± 11.6 | 0.01 |
BMI (kg/m2) a | 21.3 ± 3.6 | 19.9 ± 4.1 | 22.1 ± 3.4 | 0.03 |
Severity of Score | ||||
APACHE II | 20 ± 7 | 22 ± 8 | 20 ± 7 | 0.37 |
SOFA | 8 (5–11) | 8 (5–10) | 8 (6–11) | 0.80 |
Comorbidities, n (%) | ||||
Hypertension | 34 (47.9) | 6 (46.2) | 28 (48.3) | 0.89 |
COPD | 28 (39.4) | 6 (46.2) | 22 (37.9) | 0.58 |
Coronary Heart Disease | 19 (26.8) | 4 (30.8) | 15 (25.9) | 0.99 |
Diabetes | 18 (25.4) | 2 (15.4) | 16 (27.6) | 0.58 |
Chronic Kidney Disease | 6 (8.5%) | 1 (7.7) | 5 (8.6) | NA |
Bronchiectasis | 8 (11.3) | 1 (7.7) | 7 (12.1) | NA |
Asthma | 2 (2.8) | 1 (7.7) | 1 (1.7) | 0.34 |
Rheumatic Heart Disease | 1 (1.4) | 0 (0) | 1 (1.7) | NA |
Complications, n (%) | ||||
Surgical Factors | 14 (19.7) | 1 (7.7) | 13 (22.4) | 0.41 |
Heart Surgery | 13 (18.3) | 1 (7.7) | 12 (20.7) | 0.49 |
Trauma | 1 (1.4) | 0 (0) | 1 (1.7) | NA |
Internal Medicine Factors | 57 (80.3) | 12 (92.3) | 45 (77.6) | 0.41 |
Severe Pneumonia | 48 (67.6) | 10 (76.9) | 38 (65.5) | 0.64 |
AECOPD | 25 (35.2) | 5 (38.5) | 20 (34.5) | NA |
Sepsisa | 18 (25.4) | 7 (53.8) | 11 (19.0) | 0.02 |
AKI | 17 (23.9) | 4 (30.8) | 13 (22.4) | 0.78 |
Bronchiectasis Infection | 8 (11.3) | 1 (7.7) | 7 (12.1) | NA |
ARDS | 7 (9.9) | 3 (23.1) | 4 (6.9) | 0.21 |
Asthma Exacerbation | 3 (4.2) | 1 (7.7) | 2 (3.4) | 0.46 |
Acute Coronary Syndrome | 3 (4.2) | 0 (0) | 3 (5.2) | NA |
Heart Valve Disease | 2 (2.8) | 0 (0) | 2 (3.4) | NA |
Liver Failure | 1 (1.4) | 0 (0) | 1 (1.7) | NA |
Acute Suppurative Cholangitis | 1 (1.4) | 0 (0) | 1 (1.7) | NA |
aP < 0.05; Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant. BMI Body Mass Index, APACHE II Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, COPD Chronic Obstructive Pulmonary Disease, AECOPD Acute Exacerbation of Chronic Obstructive Pulmonary Disease, AKI Acute Kidney Injury, ARDS Acute Respiratory Distress Syndrome